| Primary |
| Product Used For Unknown Indication |
24.3% |
| Sciatica |
18.9% |
| Pain |
8.1% |
| Hypertension |
5.4% |
| Myocardial Ischaemia |
5.4% |
| Pneumonia |
5.4% |
| Antibiotic Prophylaxis |
2.7% |
| Aortic Valve Disease |
2.7% |
| Atrial Fibrillation |
2.7% |
| Back Pain |
2.7% |
| Dental Care |
2.7% |
| Drug Use For Unknown Indication |
2.7% |
| Erysipelas |
2.7% |
| Malaise |
2.7% |
| Musculoskeletal Chest Pain |
2.7% |
| Peripheral Arterial Occlusive Disease |
2.7% |
| Prophylaxis |
2.7% |
| Urinary Tract Infection Bacterial |
2.7% |
|
| Cytolytic Hepatitis |
8.3% |
| Eczema |
8.3% |
| Haemorrhage |
8.3% |
| International Normalised Ratio Increased |
8.3% |
| Intestinal Haemorrhage |
8.3% |
| Malaise |
8.3% |
| Melaena |
8.3% |
| Palatal Oedema |
8.3% |
| Pancytopenia |
8.3% |
| Pharyngeal Haemorrhage |
8.3% |
| Pharyngeal Oedema |
8.3% |
| Pruritus |
8.3% |
|
| Secondary |
| Product Used For Unknown Indication |
18.7% |
| Pyrexia |
9.1% |
| Asthenia |
8.5% |
| Myalgia |
8.5% |
| Drug Use For Unknown Indication |
7.9% |
| Cholelithiasis |
6.9% |
| Influenza |
6.6% |
| Cholecystectomy |
6.0% |
| Pneumonia |
6.0% |
| Sciatica |
4.2% |
| Haemorrhoids |
3.0% |
| Self Injurious Behaviour |
3.0% |
| Asthma |
2.1% |
| Hypertension |
2.1% |
| Preoperative Care |
1.5% |
| Urinary Tract Infection |
1.5% |
| Back Pain |
1.2% |
| Toothache |
1.2% |
| Gastroenteritis Viral |
0.9% |
| Peripheral Arterial Occlusive Disease |
0.9% |
|
| Renal Failure Acute |
16.3% |
| Stevens-johnson Syndrome |
11.6% |
| Urticaria |
9.3% |
| Renal Failure |
7.0% |
| Alveolar Proteinosis |
4.7% |
| Cytolytic Hepatitis |
4.7% |
| Malaise |
4.7% |
| Pneumonia |
4.7% |
| Respiratory Disorder |
4.7% |
| Respiratory Distress |
4.7% |
| Swelling Face |
4.7% |
| Toxic Skin Eruption |
4.7% |
| Cellulitis |
2.3% |
| Dermatitis Bullous |
2.3% |
| Dyspnoea |
2.3% |
| Gamma-glutamyltransferase Increased |
2.3% |
| Hepatocellular Injury |
2.3% |
| Hypokalaemia |
2.3% |
| Meningitis Viral |
2.3% |
| Pallor |
2.3% |
|
| Concomitant |
| Pain |
25.7% |
| Product Used For Unknown Indication |
20.4% |
| Drug Use For Unknown Indication |
6.1% |
| Gastrointestinal Stromal Tumour |
5.8% |
| Hypertension |
5.6% |
| Myeloma Recurrence |
4.8% |
| Prophylaxis |
4.0% |
| Rheumatoid Arthritis |
3.7% |
| Headache |
2.9% |
| Infection Prophylaxis |
2.9% |
| Depression |
2.6% |
| Back Pain |
2.1% |
| Constipation |
1.9% |
| Multiple Myeloma |
1.9% |
| Pain In Extremity |
1.9% |
| Breast Cancer |
1.6% |
| Colorectal Cancer |
1.6% |
| Herpes Zoster |
1.6% |
| Hypothyroidism |
1.6% |
| Nausea |
1.6% |
|
| Status Epilepticus |
11.7% |
| Thrombocytopenia |
10.0% |
| Neutropenia |
8.3% |
| Toxic Skin Eruption |
8.3% |
| Pyrexia |
6.7% |
| Off Label Use |
5.0% |
| Overdose |
5.0% |
| Pulmonary Embolism |
5.0% |
| Death |
3.3% |
| Haemorrhage |
3.3% |
| Hepatitis |
3.3% |
| Hyporeflexia |
3.3% |
| Leukopenia |
3.3% |
| Lymphoedema |
3.3% |
| Rash |
3.3% |
| Rash Erythematous |
3.3% |
| Rectal Haemorrhage |
3.3% |
| Respiratory Failure |
3.3% |
| Reversible Posterior Leukoencephalopathy Syndrome |
3.3% |
| Urticaria |
3.3% |
|
| Interacting |
| Hypertension |
66.7% |
| Headache |
33.3% |
|
| Renal Failure Acute |
100.0% |
|
